Abbvie Inc
NYSE:ABBV
Abbvie Inc
Other
Abbvie Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Other
$-742m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-9%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other
$-278m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other
$-72m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-28%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other
$-226.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-68%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other
$-700.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Seagen Inc
NASDAQ:SGEN
|
Other
$-12.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Other?
Other
-742m
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other amounts to -742m USD.
What is Abbvie Inc's Other growth rate?
Other CAGR 10Y
-9%
Over the last year, the Other growth was 33%. The average annual Other growth rates for Abbvie Inc have been -31% over the past three years , -48% over the past five years , and -9% over the past ten years .